Key result
Male infertility and non-obstructive azoospermia are linked to higher risks of cardiovascular disease and mortality.
Why the study?
Are men with infertility and non-obstructive azoospermia at higher risk for adverse health outcomes compared to fertile men?
Are men with infertility and non-obstructive azoospermia at higher risk for adverse health outcomes compared to fertile men?
Answers are grounded in this paper and cite their sources.
Men with non-obstructive azoospermia face heightened risks for mortality, cancer, and cardiometabolic diseases, warranting comprehensive health assessments and ongoing monitoring.
Non-obstructive azoospermia is a common condition associated with significant health risks, including increased mortality, cancer, and chronic diseases such as metabolic and cardiovascular disorders. This review aims to highlight the potential health challenges faced by men with this condition compared to fertile counterparts. Through a comprehensive bibliographic search on PubMed, using the following algorithm: ("infertility, male" [MeSH Terms] OR "azoospermia" [MeSH Terms]) AND ("mortality" [MeSH Terms] OR "neoplasms" [MeSH Terms] OR "chronic disease" [MeSH Terms] OR "diabetes mellitus" [MeSH Terms] OR "heart diseases" [MeSH Terms]), we analyzed existing literature to explore the associations between infertility, specifically azoospermia, and adverse health outcomes. Findings indicate that infertile men are at a higher risk of death, various cancers (particularly testicular cancer), metabolic syndrome, diabetes, hypogonadism, and cardiovascular disease. Although research specifically addressing azoospermia is limited, available studies support the notion that men with this condition may experience heightened health vulnerabilities. Given these risks, it is imperative for healthcare professionals, especially urologists, to conduct thorough health assessments for men diagnosed with azoospermia. Informing patients of these potential health issues and integrating comprehensive evaluations into their care can facilitate early detection and intervention for life-threatening conditions. Ultimately, men with azoospermia should receive ongoing monitoring to address their specific health concerns, thus improving their long-term health outcomes.
No takes yet. Share an insight, caveat, or question.
Huyghe et al. (2025) conducted a review in Non-obstructive azoospermia and male infertility. Non-obstructive azoospermia and male infertility vs. Fertile men was evaluated on Adverse health outcomes including mortality, cancers, and chronic diseases. Male infertility and non-obstructive azoospermia are associated with higher risks of mortality, cancers, metabolic syndrome, diabetes, hypogonadism, and cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: